Suppr超能文献

撒哈拉以南非洲地区多发性硬化症管理的当前实践、挑战及未来方向

Current Practices, Challenges, and Future Directions in Multiple Sclerosis Management in Sub-Saharan Africa.

作者信息

Aderinto Nicholas

机构信息

From the Internal Medicine Department, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.

出版信息

Int J MS Care. 2025 Apr 15;27(Theme):T13-T16. doi: 10.7224/1537-2073.2024-080. eCollection 2024 Dec.

Abstract

Multiple sclerosis (MS) is a chronic, inflammatory, and neurodegenerative condition characterized by the immune system's attack on the myelin sheath, leading to neurological dysfunction. While the prevalence of MS in Africa remains lower than in other regions, it has been rising steadily in recent years, with unique challenges hindering its effective management. These challenges include limited health care resources, inadequate diagnostic tools, financial constraints on accessing disease-modifying therapies, and a lack of trained health care professionals (HCPs). Cultural stigma surrounding MS further complicates patient care and treatment adherence. However, ongoing efforts by patient organizations, international collaborations, and local HCPs are focused on raising awareness, enhancing diagnosis and treatment access, and training HCPs. Future directions include integrating MS into national health policies, expanding education and research initiatives, and improving patient support networks. These efforts are vital in addressing the growing burden of MS in Africa and ensuring equitable access to care.

摘要

多发性硬化症(MS)是一种慢性、炎症性和神经退行性疾病,其特征是免疫系统攻击髓鞘,导致神经功能障碍。虽然非洲MS的患病率仍低于其他地区,但近年来一直在稳步上升,存在一些独特的挑战阻碍其有效管理。这些挑战包括医疗资源有限、诊断工具不足、获取疾病修正疗法的资金限制以及缺乏训练有素的医疗保健专业人员(HCPs)。围绕MS的文化耻辱感进一步使患者护理和治疗依从性复杂化。然而,患者组织、国际合作和当地HCPs正在进行的努力集中在提高认识、增加诊断和治疗机会以及培训HCPs。未来的方向包括将MS纳入国家卫生政策、扩大教育和研究倡议以及改善患者支持网络。这些努力对于应对非洲日益增长的MS负担以及确保公平获得护理至关重要。

相似文献

1
Current Practices, Challenges, and Future Directions in Multiple Sclerosis Management in Sub-Saharan Africa.
Int J MS Care. 2025 Apr 15;27(Theme):T13-T16. doi: 10.7224/1537-2073.2024-080. eCollection 2024 Dec.
3
Navigating the journey of multiple sclerosis management in Africa, overcoming hurdles and harnessing opportunities: a review.
Ann Med Surg (Lond). 2023 Apr 6;85(5):1774-1779. doi: 10.1097/MS9.0000000000000560. eCollection 2023 May.
4
Neuro-oncology access in Sub-Saharan Africa: A literature review of challenges and opportunities.
Neurooncol Adv. 2024 Jul 11;6(1):vdae057. doi: 10.1093/noajnl/vdae057. eCollection 2024 Jan-Dec.
5
The benefits, barriers, and specific needs of palliative care for adults with cancer in sub-Saharan Africa: a systematic review.
Glob Health Action. 2025 Dec;18(1):2485742. doi: 10.1080/16549716.2025.2485742. Epub 2025 Apr 10.
6
The current state of pediatric gastroenterology in under-resourced nations.
Ann Med Surg (Lond). 2025 Mar 7;87(4):2218-2228. doi: 10.1097/MS9.0000000000003141. eCollection 2025 Apr.
7
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions.
Int J Equity Health. 2023 Sep 11;22(1):189. doi: 10.1186/s12939-023-01962-y.

本文引用的文献

1
Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.
Nature. 2024 Jan;625(7994):321-328. doi: 10.1038/s41586-023-06618-z. Epub 2024 Jan 10.
2
Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
Mult Scler Relat Disord. 2023 Dec;80:105092. doi: 10.1016/j.msard.2023.105092. Epub 2023 Oct 21.
3
Barriers to accessing multiple sclerosis disease-modifying therapies in the Middle East and North Africa region: A regional survey-based study.
Mult Scler Relat Disord. 2023 Nov;79:104959. doi: 10.1016/j.msard.2023.104959. Epub 2023 Aug 21.
4
The essential role of neuroimaging in diagnosing and managing cerebrovascular disease in Africa: a review.
Ann Med. 2023;55(2):2251490. doi: 10.1080/07853890.2023.2251490. Epub 2023 Aug 29.
5
Navigating the journey of multiple sclerosis management in Africa, overcoming hurdles and harnessing opportunities: a review.
Ann Med Surg (Lond). 2023 Apr 6;85(5):1774-1779. doi: 10.1097/MS9.0000000000000560. eCollection 2023 May.
6
Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019.
Front Public Health. 2023 Feb 17;11:1073278. doi: 10.3389/fpubh.2023.1073278. eCollection 2023.
7
Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients.
Sci Rep. 2023 Feb 8;13(1):2249. doi: 10.1038/s41598-023-28864-x.
9
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments.
CNS Drugs. 2022 Aug;36(8):803-817. doi: 10.1007/s40263-022-00939-9. Epub 2022 Jul 22.
10
Defining routine fatigue care in Multiple Sclerosis in the United Kingdom: What treatments are offered and who gets them?
Mult Scler J Exp Transl Clin. 2022 Jan 20;8(1):20552173211072274. doi: 10.1177/20552173211072274. eCollection 2022 Jan-Mar.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验